Alzheimer's risk genes change susceptibility; inherited disease-causing variants directly cause Alzheimer's in people who inherit them. A risk gene raises or lowers the odds, while a deterministic variant is expected to cause disease. The distinction matters because most Alzheimer's disease results from multiple genes plus lifestyle and environmental influences, not one inherited cause. Genetic results can inform a family's questions, but they do not always predict one person's future.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What is the difference?
- Which inherited variants cause Alzheimer's?
- What does APOE ε4 actually tell you?
- Should you get genetic testing?
- What should families take from a result?
- Frequently Asked Questions
What is the difference?
A risk gene changes susceptibility rather than guaranteeing Alzheimer's disease. The best-known example is APOE ε4, a genetic variant associated with late-onset Alzheimer's. One copy raises risk, and two copies raise it further, but some carriers never develop Alzheimer's, according to the National Institute on Aging's genetics fact sheet National Institute on Aging.
A disease-causing, or deterministic, variant directly causes disease in people who inherit it. These variants are rare and belong to specific genes linked with autosomal-dominant Alzheimer's disease, a form that can pass from an affected parent to a child. Family history alone does not show which category applies. Several relatives may have Alzheimer's because of shared genes, shared exposures, or both.
Which inherited variants cause Alzheimer's?
Rare pathogenic variants in APP, PSEN1, and PSEN2 can cause autosomal-dominant Alzheimer's disease. Symptoms usually begin before age 65. If a parent carries one of these variants, each child has a 50% chance of inheriting it, according to the National Institute on Aging its Alzheimer's disease genetics fact sheet.
These variants explain only 10% to 15% of early-onset Alzheimer's cases. Early-onset disease itself accounts for less than 10% of all Alzheimer's cases, so most people with Alzheimer's do not have one of these clearly inherited causes. A strong pattern of early symptoms across generations is more relevant to this type of testing than a single older relative with dementia. The family pattern still requires clinical assessment rather than assumptions based on ancestry or memory alone.
What does APOE ε4 actually tell you?
APOE ε4 is a risk allele, meaning a gene version associated with a higher likelihood of disease. It is not, by itself, proof that a person will develop Alzheimer's or an explanation for every case in a family. Its effect also varies with genetic ancestry.
The National Institute on Aging notes that APOE ε4's association with Alzheimer's risk is not uniform across populations, so one risk estimate cannot be applied equally to everyone National Institute on Aging. The boundary between "risk" and "deterministic" is being reconsidered for people with two APOE ε4 copies. A 2024 study, conducted largely in people of European descent, found near-universal Alzheimer's pathology after age 55 and estimated a 60% dementia risk by age 85, according to the National Institute on Aging study summary. Those findings do not make every APOE result a diagnosis or provide the same estimate for every population.
Should you get genetic testing?
Genetic testing is not routinely used to diagnose or predict Alzheimer's disease. APOE testing cannot fully predict whether someone will develop the disease, so results require counseling.
Clinicians may consider testing for APP, PSEN1, and PSEN2 when a person has early symptoms and a strong family history. A decision to test is more relevant when several features occur together: A positive deterministic result can identify an inherited cause, but a negative result does not explain every case of early-onset disease. A risk result, such as APOE ε4, changes probability without settling the person's outcome.
- Symptoms began before age 65.
- Multiple relatives developed Alzheimer's at relatively young ages.
- The family pattern suggests autosomal-dominant inheritance.
- The person understands that results may affect relatives as well as themselves.
What should families take from a result?
A risk gene result should not be treated like a diagnosis. It describes susceptibility within a larger picture that includes other genes, lifestyle, and environmental influences. An inherited disease-causing variant has a different meaning: it can explain a strong family pattern and has implications for biological relatives because each child of a carrier faces a 50% inheritance chance.
That is why testing decisions are best handled with clinical guidance and genetic counseling. For most families, the practical first step is to document relatives' diagnoses and approximate ages of onset, then discuss the pattern with a clinician. Testing may be considered when early symptoms and strong family history point toward APP, PSEN1, or PSEN2; APOE results require particular caution because they do not fully predict disease.
Frequently Asked Questions
Does having APOE ε4 mean I will develop Alzheimer's?
No. APOE ε4 raises risk, especially with two copies, but some carriers never develop Alzheimer's.
Is Alzheimer's usually caused by one inherited variant?
No. Most cases involve multiple genes along with lifestyle and environmental influences.
What genes are linked to inherited, autosomal-dominant Alzheimer's?
Rare pathogenic variants in APP, PSEN1, and PSEN2 can directly cause this form of disease.
Can genetic testing diagnose Alzheimer's?
It is not routinely used to diagnose or predict Alzheimer's. Testing for disease-causing variants may be considered when early symptoms occur with a strong family history.
